We have previously reported in a PLIN2 knock-out mouse model that reducing hepatocellular LD storage capacity not only prevents alcoholic steatosis but also improves glucose tolerance and insulin resistance (clinical factors associated with the development of advanced ALD)7, suggesting that modulation of steatosis itself may lower the risk of advanced ALD. The gene discussed is PLIN2; the disease is steatosis.